Potential changes to the FDA approach to biosimilars have a global impact

Pekka Kurki

Research output: Contribution to journalEditorialScientific

Original languageEnglish
JournalGaBI Journal
Volume7
Issue number2
Pages (from-to)53-55
Number of pages3
ISSN2033-6403
DOIs
Publication statusPublished - 2018
MoE publication typeB1 Journal article

Fields of Science

  • Automatic substitution
  • FDA guidelines
  • global reference product
  • information
  • interchangeability
  • regulatory harmonization
  • 317 Pharmacy

Cite this